# EASYTRAK 3 Downsize Lead

> **NCT00384722** · PHASE2,PHASE3 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 70 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** EASYTRAK 3 Downsize Lead

## Key facts

- **NCT ID:** NCT00384722
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2006-07
- **Final completion:** 2008-05
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2009-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384722, "EASYTRAK 3 Downsize Lead". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00384722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*